Empo Health has secured $7 million in funding to enhance its innovative home-based diabetic foot ulcer (DFU) monitoring system, which aims to revolutionize care for the more than 20 million Americans at risk due to diabetic neuropathy. The funding, led by Story Ventures, pushes their total capital to $15 million. Empo’s technology integrates an imaging scale and a compliant health service to enable early detection of foot issues, significantly reducing potential amputation risks and healthcare costs. Their pilot study indicated promising results, showcasing the effectiveness of remote monitoring solutions in patient care.
Empo Health has raised $7 million to further develop its diabetic foot ulcer monitoring system, aiming for early detection to prevent amputations and reduce healthcare costs.
More than 20 million Americans suffer from diabetic neuropathy, placing them at high risk for foot ulcers—a condition linked to significant healthcare spending.
Empo’s monitoring system allows patients to capture images of their feet easily, enabling remote monitoring by healthcare providers to detect problems early.
CEO Anuj Khandelwal emphasized the importance of the system: "We founded Empo to meet patients where they are in their homes...to prevent avoidable amputations."
Collection
[
|
...
]